by David Brindley | Oct 25, 2013
. Nestled in the bosom of the Canadian Rockies, the global regenerative medicine community is assembled. Coaches laden with young investigators sporting impractically packed posters and drawn, jet lagged expressions are arriving in a steady procession. The usually...
by David Brindley | Oct 24, 2013
. 9am, Day 1: IBC Cell Therapy Bioprocessing Conference (Bethesda, MD, USA): Attempting to sharpen tie, and my welcome isolation is interrupted by a lady entering the elevator and fighting for mirror space. Cue small talk: “That’s a nice tie.” “Erm, thank you.” “And...
by David Brindley | Oct 23, 2013
. The Cell Therapy Industry’s equivalent of ‘Wimbledon Fortnight,’ is upon us: ARM’s successfully delivered Meeting on the Mesa (La Jolla, CA) has served as a tantalizing hors d’oeuvre to IBC’s Cell Therapy Bioprocessing Conference (Bethesda, MD) and CCRM’s and...
by Lisa Willemse | Oct 21, 2013
> If the thought of majestic mountains, impossibly blue skies and natural hot springs isn’t enough to put Banff, Alberta into your calendar this week, then perhaps this preview of the Till & McCulloch Meetings will change your mind. This is the second...
by Mark Curtis | Oct 17, 2013
. Welcome to the first Regenerative Medicine Deal Review, an overview of recent licensing, partnering, and financing activity all exclusively in the regenerative medicine and cell therapy industries. Like my first post ‘Update from the Clinic’, this piece is intended...
by Paul Krzyzanowski | Oct 8, 2013
This is part two of a series on Michael West. Read part one. When most people hear of new applications coming out of stem cell research it’s usually via headline grabbing soon-to-be-products like stem cell derived livers, replacement ears, transplantable retinas,...
Comments